US Stock MarketDetailed Quotes

Lixte Biotechnology (LIXT)

Watchlist
  • 3.350
  • +0.190+6.01%
Close Jan 22 16:00 ET
  • 3.350
  • 0.0000.00%
Post 16:04 ET
29.16MMarket Cap-2.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lixte Biotechnology (LIXT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.22%-926.75K
40.48%-487.49K
27.97%-568.48K
26.29%-3.16M
33.64%-598.68K
-1.40%-957.6K
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
Net income from continuing operations
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
Change In working capital
163.06%49.44K
-67.00%20.19K
-47.79%41.33K
-85.38%3.01K
-326.11%-58.96K
-107.74%-78.39K
-71.26%61.19K
143.82%79.17K
-86.71%20.56K
-30.40%26.08K
-Change in prepaid assets
-46.73%11.21K
-73.68%26.99K
67.08%-22.98K
-101.38%-1.42K
-321.54%-55.21K
-60.40%21.05K
70.12%102.56K
-94.50%-69.81K
59.15%102.46K
-52.52%24.92K
-Change in payables and accrued expense
190.45%59.22K
82.37%-20.33K
-36.87%56.77K
0.57%-73.55K
126.42%17.28K
54.96%-65.47K
-180.68%-115.28K
1,566.31%89.93K
-3,291.37%-73.98K
17.36%-65.38K
-Change in other working capital
38.19%-20.99K
-81.70%13.53K
-87.22%7.54K
1,084.32%77.98K
-131.59%-21.02K
-162.34%-33.96K
659.63%73.91K
142.58%59.05K
-109.00%-7.92K
3.81%66.54K
Cash from discontinued investing activities
Operating cash flow
3.22%-926.75K
40.48%-487.49K
27.97%-568.48K
26.29%-3.16M
33.64%-598.68K
-1.40%-957.6K
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
5.56M
-10K
914.23K
0
0
0
0
0
-38.86%3.14M
0
Net common stock issuance
--5.51M
--0
--914.23K
--0
--0
--0
--0
--0
-38.98%3.14M
--0
Proceeds from stock option exercised by employees
----
----
----
--0
--0
--0
--0
--0
--6.32K
--0
Cash from discontinued financing activities
Financing cash flow
--5.56M
---10K
--914.23K
--0
--0
--0
--0
--0
-38.86%3.14M
--0
Net cash flow
Beginning cash position
-65.81%887.21K
-59.44%1.38M
-75.28%1.04M
-21.48%4.2M
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
10.98%5.35M
-22.19%5.11M
Current changes in cash
308.93%2M
39.26%-497.49K
143.81%345.75K
-175.20%-3.16M
33.64%-598.68K
-143.67%-957.6K
30.32%-819.04K
37.62%-789.23K
-317.11%-1.15M
25.35%-902.12K
End cash Position
76.35%2.89M
-65.81%887.21K
-59.44%1.38M
-75.28%1.04M
-75.28%1.04M
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
Free cash flow
3.22%-926.75K
40.48%-487.49K
27.97%-568.48K
26.29%-3.16M
33.64%-598.68K
-1.40%-957.6K
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.22%-926.75K40.48%-487.49K27.97%-568.48K26.29%-3.16M33.64%-598.68K-1.40%-957.6K30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K
Net income from continuing operations -100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M
Change In working capital 163.06%49.44K-67.00%20.19K-47.79%41.33K-85.38%3.01K-326.11%-58.96K-107.74%-78.39K-71.26%61.19K143.82%79.17K-86.71%20.56K-30.40%26.08K
-Change in prepaid assets -46.73%11.21K-73.68%26.99K67.08%-22.98K-101.38%-1.42K-321.54%-55.21K-60.40%21.05K70.12%102.56K-94.50%-69.81K59.15%102.46K-52.52%24.92K
-Change in payables and accrued expense 190.45%59.22K82.37%-20.33K-36.87%56.77K0.57%-73.55K126.42%17.28K54.96%-65.47K-180.68%-115.28K1,566.31%89.93K-3,291.37%-73.98K17.36%-65.38K
-Change in other working capital 38.19%-20.99K-81.70%13.53K-87.22%7.54K1,084.32%77.98K-131.59%-21.02K-162.34%-33.96K659.63%73.91K142.58%59.05K-109.00%-7.92K3.81%66.54K
Cash from discontinued investing activities
Operating cash flow 3.22%-926.75K40.48%-487.49K27.97%-568.48K26.29%-3.16M33.64%-598.68K-1.40%-957.6K30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 5.56M-10K914.23K00000-38.86%3.14M0
Net common stock issuance --5.51M--0--914.23K--0--0--0--0--0-38.98%3.14M--0
Proceeds from stock option exercised by employees --------------0--0--0--0--0--6.32K--0
Cash from discontinued financing activities
Financing cash flow --5.56M---10K--914.23K--0--0--0--0--0-38.86%3.14M--0
Net cash flow
Beginning cash position -65.81%887.21K-59.44%1.38M-75.28%1.04M-21.48%4.2M-67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M10.98%5.35M-22.19%5.11M
Current changes in cash 308.93%2M39.26%-497.49K143.81%345.75K-175.20%-3.16M33.64%-598.68K-143.67%-957.6K30.32%-819.04K37.62%-789.23K-317.11%-1.15M25.35%-902.12K
End cash Position 76.35%2.89M-65.81%887.21K-59.44%1.38M-75.28%1.04M-75.28%1.04M-67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M
Free cash flow 3.22%-926.75K40.48%-487.49K27.97%-568.48K26.29%-3.16M33.64%-598.68K-1.40%-957.6K30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -